Sai Life In Q4
For the March quarter, Sai Life’s net profit increased by 18.1% to ₹104.23 crore from last year’s ₹88.27 crore. When compared to the previous quarter, the profit figure was up 4%.
The company’s topline growth during the quarter was subdued at 3.9% to ₹602.13 crore from ₹579.5 crore last year. On a sequential basis though, the revenue figure was up 8%.
Earnings before interest, tax, depreciation and amortisation (EBITDA) increased by 12% to ₹176.54 crore from ₹157.57 crore in the fourth quarter last year. However, the figure was down 6% from the December quarter.
EBITDA margins expanded to 29.3% from 27.2% in the year-ago period but contracted from the 34% reported in the previous quarter.
Sai Life In FY26
In the entire financial year 2026, Sai Life’s net profit increased 105% to ₹348.91 crore from ₹170.1 crore last year. Its revenue increased 32% to 2,241.62 crore in FY26 from ₹1,694.6 in the previous fiscal.
The company’s EBITDA was up 68% at ₹680.28 crore from ₹405.7 crore it reported last year, while margins expanded to 30.3% from 23.9% in the year ago period.
Stock Performance
Shares of Sai Life Sciences are now trading 11% lower at ₹990.5. The stock is the top loser on the Nifty 500 index today.
However, ahead of today’s fall, the stock had surged more than 100% from its IPO price of ₹549, and was also near its 52-week high of ₹1,139.
Also Read: Five stocks seeing the biggest fall after their Q4 results on Friday
